July 07, 2017 – A new study analyzing genetic mutations predisposing to increased body-mass index (BMI) provides strong evidence that higher BMI plays a causal role in type 2 diabetes, hypertension, and coronary heart disease (CHD). The study results strongly suggest …

Genetic Study Strengthens Causal Role of BMI in Heart Disease Read more »

Tagged with: , , , , , , ,

December 23, 2014 – The U.S. Food and Drug Administration (FDA) just approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The drug is approved for use …

The weight-management drug Liraglutide (Saxenda) has just been approved by the FDA Read more »

Tagged with: , , , , , , , , , , , ,

September 13, 2014 – The U.S. Food and Drug Administration approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The drug is approved for …

Weight-management drug Contrave approved Read more »

Tagged with: , , , ,